Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
European Urology|May 27, 2019
The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus StatementMatthew R Cooperberg, Peter R Carroll, Marc A Dall'Era, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|May 23, 2019
Cancer-related symptoms, mental well-being, and psychological distress in men diagnosed with prostate cancer treated with androgen deprivation therapySarah Wilding, Amy Downing, Penny Wright, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancerNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2007
Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancerJohann Sebastian de Bono, Joaquim Bellmunt, Gerhardt Attard, et al.
European Urology|June 9, 2012
A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancerJoshua J Meeks, Joaquim Bellmunt, Bernard H Bochner, et al.
Nature Reviews. Clinical Oncology|August 8, 2019
Global Consultation on Cancer Staging: promoting consistent understanding and useJames Brierley, Brian O'Sullivan, Hisao Asamura, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.
Pageof 29